The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Expires: July 31, 2015
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
BIOHAVEN LTD COM G1110E107 43,695,224 2,936,507 SH DFND 1, 2 2,936,507 0 0
CYTOKINETICS, INC COM 23282W605 83,519,594 980,392 SH DFND 1, 2 980,392 0 0
ZENAS BIOPHARMA, INC. COM 055477103 60,611,247 2,388,150 SH DFND 1, 2 2,388,150 0 0
KAILERA THERAPEUTICS COM 482931102 54,091,515 2,455,357 SH DFND 1, 2 2,455,357 0 0